Facialis
ActiveFacialis has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €430k and a net result of €217k. Equity is growing by ~33.3% per year across the filed fiscal years. Its solvency ranks better than 41% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
94
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100▲+4
Solvency83▲+23
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 2.78 against 1.87 in 2023; short-term debt: 28.9% and cash: 35.8% of total assets), and 41.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
58.3%
Return on assets
29.4%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 17-07-2025, 14 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
not confirmed
2024
14 d early
2023
2 d early
2022
28 d early
2021
34 d early
2020
33 d early
2019
27 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€430k▲ 102%
2023 · €213k
2019: €60k
2020: €114k
2021: €218k
2022: €275k
2023: €213k
2019 → 2024
Total assets
€737k▲ 20.2%
2023 · €613k
2019: €323k
2020: €351k
2021: €496k
2022: €840k
2023: €613k
2019 → 2024
Net result
€217k▲ 63.2%
2023 · €133k
2019: €41k
2020: €54k
2021: €104k
2022: €57k
2023: €133k
2019 → 2024
Working capital
€379k▲ 54.9%
2023 · €245k
2019: €-61k
2020: €94k
2021: €198k
2022: €279k
2023: €245k
2019 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€114k-€218k▲ 92.0%€275k▲ 26.1%€213k▼ 22.6%€430k▲ 102%
Operating result€71k-€141k▲ 97.0%€78k▼ 44.2%€173k▲ 120%€167k▼ 2.9%
Net result€54k-€104k▲ 93.7%€57k▼ 45.6%€133k▲ 134%€217k▲ 63.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 3% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €737k
Fixed assets
€144k▲ 69.9%
Current assets
€593k▲ 12.2%
Equity and liabilities €737k
Equity
€430k▲ 102%
Debt
€307k▼ 23.2%
The debt ratio falls from 65.3% to 41.7%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€213k▲
2023 · €212k
Cash flow
€263k▲
2023 · €173k
Solvency
58.3%▲
2023 · 34.7%
Current ratio
2.78▲
2023 · 1.87
Quick ratio
2.78▲
2023 · 1.87
Debt / equity
0.71▼
2023 · 1.88
ROE
50.5%▼
2023 · 62.5%
ROA
29.4%▲
2023 · 21.7%
Interest coverage
112.25▼
2023 · 214.88
Debt
€307k▼
2023 · €400k
Debt ≤ 1 year
€213k▼
2023 · €283k
Debt > 1 year
€94k▼
2023 · €117k
Income taxes
€49k▲
2023 · €39k
Staff costs
€6k▼
2023 · €28k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€613k€737k▲
Fixed assets21/28€85k€144k▲
Tangible fixed assets22/27€85k€144k▲
Land and buildings22€32k€29k▼
Plant, machinery and equipment23€49k€28k▼
Furniture and vehicles24€3k€88k▲
Current assets29/58€528k€593k▲
Current investments50/53€326k€326k=
Cash at bank and in hand54/58€199k€263k▲
Deferred charges and accrued income490/1€2k€3k▲
Equity and liabilities
Total equity and liabilities10/49€613k€737k▲
Equity10/15€213k€430k▲
Contributions10/11€19k€19k=
Reserves13€194k€411k▲
Distributable reserves133€194k€411k▲
Amounts payable17/49€400k€307k▼
Amounts payable after more than one year17€117k€94k▼
Financial debts170/4€117k€94k▼
Amounts payable within one year42/48€283k€213k▼
Current portion of amounts payable after more than one year42€11k€23k▲
Trade debts44€11k€11k▼
Suppliers440/4€11k€11k▼
Taxes, remuneration and social security45€8k€33k▲
Taxes450/3€4k€33k▲
Remuneration and social security454/9€5k-
Other amounts payable47/48€252k€147k▼
Income statement
Code20232024
Remuneration, social security and pensions62€28k€6k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€40k€46k▲
Other operating charges640/8€315€2k▲
Gross operating margin9900€240k€221k▼
Operating profit (loss)9901€173k€167k▼
Financial income75/76B€13€101k▲
Recurring financial income75€13€101k▲
Financial charges65/66B€988€2k▲
Recurring financial charges65€988€2k▲
Profit (loss) for the period before taxes9903€172k€266k▲
Income taxes67/77€39k€49k▲
Profit (loss) for the period9904€133k€217k▲
Profit (loss) for the period to be appropriated9905€133k€217k▲
Appropriation of the result
Profit (loss) to be appropriated9906€133k€217k▲
Transfer from equity791/2€195k-
Transfer to equity691/2€133k€217k▲
To other reserves6921€133k€217k▲
Profit to be distributed694/7€195k-
Return on contributions (dividend)694€195k-
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
17-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2019net €217k ▲63.2%
Net result €217k, the highest in the series.
29-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
03-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
27-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Equity above €200kEq €218k ▲92%
3 profitable years in a row build equity to €218k.
28-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Liquidity triplescurrent ratio 2.07
Current ratio from 0.68 to 2.07; short-term debt falls from €192k to €87k.
31-12
Financial
Equity above €100kEq €114k ▲90.5%
2 profitable years in a row build equity to €114k.
27-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 27 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lanaken · 1 establishment unit since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Heirbaan 203620 LanakenGround area
3,899 m²
Building footprint
257 m²
Volume, LiDAR
1,567 m³
Parcel 73057A0103/00D000, Flanders · tallest building 9.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Facialis
since 20192.288.297.997
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73057A0103/00D000 | Flanders | 3,899 m² | 1 · 257 m² | 9.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. S. POURJAVAN, OOGARTS
BE 0867.484.856
Zaventem · Eq €430k
ENDUROMED
BE 0888.032.030
Deinze · Eq €430k
WMH Medic
BE 0805.193.931
Roeselare · Eq €430k
Dr. Van Sande Hilde, gynaecologie
BE 0697.653.395
Ranst · Eq €430k
Dokter J. Vermeulen
BE 0460.392.385
Geel · Eq €430k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,532 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded26-02-2019
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesWebsite:www.facialis.be
E-mail:info@facialis.be